MedPath

A STUDY OF PARSIYADI CHURNA (POWDER) IN TREATMENT OF KRIMI (WORM)

Phase 2
Conditions
Health Condition 1: B820- Intestinal helminthiasis, unspecified
Registration Number
CTRI/2021/11/037960
Lead Sponsor
DR YOGESH SUKDEV GADAKH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) THE PATIENTS PRESENTING THE SIGN AND SYMPTOM OF KRIMI SUCH AS

VAIVARNYATA(SKIN PIGMENTATION)

UDARSHUL(ABDOMINAL PAIN)

GUDAKANDU(ITCHING NEAR ANAL REGION)

VISHTAMBHATA(CONSTIPATION)

SKIN RASH(TWAKA VIVARNATA)

AGNIMANDYA (ANOREXIA)

2) CHILDREN AGE BETWEEN 1 TO 12 YEARS

3) PATIENTS WILL BE SELECTED IRRESPECTIVE OF SEX, SOCIO ECONOMIC STATUS

4) THE PATIENTS WHOSE PARENTS ARE READY TO PARTICIPATE IN THE CLINICAL TRAIL BY GIVING INFORMED WRITTEN CONSENT

Exclusion Criteria

1) PATIENTS HAVING LIFE THREATENING ILLNESS AND WHO IS BED RIDDEN

2) PATIENT WHO ARE KNOWN CASE OF CHRONIC SYSTEMIC ILLNESS

3) PATIENTS WHO HAVE OTHER THAN CLINICAL SIGN AND SYMPTOMS OF KRIMI

4) CHILDREN BELOW 1 YEAR AND ABOVE 12 YEARS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath